The role of the patient in pharmacovigilance is key. The need for early involvement of the patient in the cycle of drug development is widely recognised, and direct patient reporting of ADRs is encouraged at many levels. This is very important as there are many barriers to safe medicine use, which lead to poor adherence, overuse, or misuse.